Maybe they are holding on to data from burns trial ready to release when more cash required.
From my point of view they have done well to get to the current point in time with less than 200 million shares on issue. That seems pretty rare for a bio company that has been around a few years now. If they can get the share price above $1 running into next raise then that would be very impressive, although im sure you would disagree. Another $30 million For less than 30 million new shares would be incredible. If they can make another positive announcement either on burns or diabetic ulcers or Uti's it should move pretty quick assuming economy holds together. The more valid external data they can provide that it works surely the easier the investment decision for big guys.
It seems hard to believe that after the initial burns results were announced that it just stopped working so i assume there must be some progress being made, just not ready to be announced as yet?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)